Select for export A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811251378512 PubMed 41099491 Copy citation Copy BibTeX Journal of Psychopharmacology 2025-10-15 Gerard J. Marek, Soma Makai-Bölöni, Daniel Umbricht, Edward P. Christian, Jason Winters, Dino Dvořák OpenAlex Published psilocybin DepressionBrain ImagingPharmacology Randomized Controlled Trial More
Select for export Structure-GuidedDesign of Novel 5-HT2A Partial Agonists as PsychedelicAnalogues with Antidepressant Effects Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acs.jmedchem.5c02045.s001 Copy citation Copy BibTeX Figshare 2025-10-14 Rongyan Li (11403789), Haohan Yan (22432650), Yujin Chen (1412254), Yangyang Liu (807797), Lingjie Tang (9276407), Jing Yu (81085) OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Animal Study More
Select for export Analysis of Serotonin in Caenorhabditis Elegans Subjected to Micro-Dosing with Psilocybin| Iris Publishers Abstract available at the source but not redistributed here. Read at source. Details DOI 10.33552/icbc.2025.03.000562 Copy citation Copy BibTeX Insights in Chemistry and Biochemistry 2025-10-14 Douglas B. Craig OpenAlex Published psilocybin Receptor PharmacologyToxicity Other More
Select for export Psilocybin exerts differential effects on social behaviour and inflammation in mice in contexts of activity-based anorexia (ABA) Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2025.10.14.682467 Copy citation Copy BibTeX bioRxiv 2025-10-14 Shadani S, Greaves E, Andrews ZB, Foldi CJ. bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyOCD Animal Study More
Select for export Psychedelics in the context of stress and psychiatric disorders: A new horizon in mental health treatment Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61373/pp025v.0038 Copy citation Copy BibTeX Psychedelics. 2025-10-13 Sha Jin, H.Y. Wang, Xiaohui Wang OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Intravenous Administration of Serotonergic Psychedelics Produce Short-lasting Changes in Sleep-Wake Behavior and High Gamma Functional Connectivity in Rats Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2025.10.12.681880 Copy citation Copy BibTeX bioRxiv 2025-10-13 Kolbman N, Huels ER, Nelson A, Summerfield R, Byraju K, Groenhout T bioRxiv PREPRINT (not peer reviewed) psilocybin Brain Imaging Other More
Select for export Structure-Guided Design of Novel 5-HT2A Partial Agonists as Psychedelic Analogues with Antidepressant Effects Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acs.jmedchem.5c02045 PubMed 41087124 Copy citation Copy BibTeX Journal of Medicinal Chemistry 2025-10-13 Rongyan Li, Haohan Yan, Yujin Chen, Yangyang Liu, Lingjie Tang, Jing Yu OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Animal Study More
Select for export Psychedelic 5-HT2A receptor agonism alters neurovascular coupling and differentially affects neuronal and hemodynamic measures of brain function. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41593-025-02069-z PubMed 41083844 Copy citation Copy BibTeX Unknown journal 2025-10-12 Padawer-Curry JA, Krentzman OJ, Kuo CC, Wang X, Bice AR, Nicol GE Europe PMC Published psilocybin Brain ImagingReceptor PharmacologyAging Animal Study More
Select for export Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acschemneuro.5c00667 PubMed 41078264 Copy citation Copy BibTeX ACS Chemical Neuroscience 2025-10-12 Rajiv Agrawal, Daniel J. Gillie, Alison E. Mungenast, Milan Chytil, Sharon Engel, Michael C. Wu OpenAlex Published psilocybin DepressionAddictionNeuroplasticity Animal Study More
Select for export Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-025-06913-9 PubMed 41073618 Copy citation Copy BibTeX Psychopharmacology 2025-10-10 St Pierre M, Argento E, Cates J, Kryskow P, Harvey K, Stamets P PubMed Published psilocybin MicrodosingObservational Study Observational Study More
Select for export Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.genhosppsych.2025.10.010 PubMed 41109203 Copy citation Copy BibTeX General Hospital Psychiatry 2025-10-10 Yvan Beaussant, Elise C. Tarbi, Kabir Nigam, Skye A. Miner, Zachary Sager, Justin J. Sanders OpenAlex Published psilocybin DepressionChronic PainToxicity Qualitative Study More
Select for export Psychedelics in Practice: Science, Safety, and the Future of Healing Abstract available at the source but not redistributed here. Read at source. Details DOI 10.54389/epsd8792 Copy citation Copy BibTeX The proceedings of sliit international conference on advancements in science and humanities 2025-10-09 Renee Ireland OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Control group improvement lower in psilocybin trials for depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pu.31371 Copy citation Copy BibTeX The Brown University Psychopharmacology Update 2025-10-09 Authors unavailable OpenAlex Published psilocybin DepressionReceptor PharmacologyClinical Trial Randomized Controlled Trial More
Select for export Psilocybin’s effect on human brain synaptic plasticity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-7469144/v1 Copy citation Copy BibTeX Research Square 2025-10-09 Johansen A, Plavén-Sigray P, Madsen MK, Søndergaard A, Messel C, Geisler M Europe PMC PREPRINT (not peer reviewed) psilocybin NeuroplasticityMechanism of ActionMystical Experience Other More
Select for export Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO Study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.17615/qr51-1n44 Copy citation Copy BibTeX UNC Libraries 2025-10-08 Vanessa Zavala Cruz, Lynnette A. Averill, David S. Mathai, James J. Crowley, Muñoz, Josselyn S OpenAlex Published psilocybin AddictionOCDGenomics Other More
Select for export Neurocomputational evidence of sustained Self-Other mergence after psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2025.10.07.25337510 Copy citation Copy BibTeX medRxiv 2025-10-07 Mallaroni P, Mason NL, Preller KH, Razi A, Ereira S, Ramaekers JG. medRxiv PREPRINT (not peer reviewed) psilocybin Brain ImagingWellbeing Other More
Select for export Synaptic priming: A framework for pharmacotherapy in depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuron.2025.09.010 PubMed 41067229 Copy citation Copy BibTeX Unknown journal 2025-10-07 Brown KA, Ajibola MI, Medeiros GC, Gould TD. Europe PMC Published psilocybin DepressionNeuroplasticityPharmacology Review Article More
Select for export Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.69613/thv1dn30 Copy citation Copy BibTeX Journal of Pharma Insights and Research. 2025-10-04 M Loganathan, A Saravanakumar, P. Parthiban, G Anandharaj, S Gobika, D Dharshana OpenAlex Published psilocybinpsilocin DepressionEnd-of-Life DistressChronic Pain Clinical Trial More
Select for export Harm reduction practises for users of psychedelic drugs: a scoping review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s12954-025-01264-2 PubMed 41044617 Copy citation Copy BibTeX Harm reduction journal 2025-10-02 Dutton C, North E, Chun Tie Y, Oliva J, Skeffington P PubMed Published psilocybin Review ArticleSafety Review Article More
Select for export An Evaluation of Therapeutic Harm Reduction and Psilocybin-Assisted Therapy Within Oregon's Measure 109 Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PDXScholar (Portland State University) 2025-10-01 Bodhi Norton OpenAlex Published psilocybin Observational StudyToxicity Observational Study More
